- Home
- FSTR vs PRQR Comparison
FSTR vs PRQR Comparison
Compare FSTR & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- PRQR
- Stock Information
- Founded
- FSTR 1902
- PRQR 2012
- Country
- FSTR United States
- PRQR Netherlands
- Employees
- FSTR N/A
- PRQR N/A
- Industry
- FSTR Metal Fabrications
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- FSTR Industrials
- PRQR Health Care
- Exchange
- FSTR Nasdaq
- PRQR Nasdaq
- Market Cap
- FSTR 230.9M
- PRQR 179.1M
- IPO Year
- FSTR N/A
- PRQR 2014
- Fundamental
- Price
- FSTR $23.87
- PRQR $2.24
- Analyst Decision
- FSTR Hold
- PRQR Strong Buy
- Analyst Count
- FSTR 1
- PRQR 8
- Target Price
- FSTR $25.00
- PRQR $8.88
- AVG Volume (30 Days)
- FSTR 33.8K
- PRQR 356.8K
- Earning Date
- FSTR 08-05-2025
- PRQR 08-07-2025
- Dividend Yield
- FSTR N/A
- PRQR N/A
- EPS Growth
- FSTR 361.43
- PRQR N/A
- EPS
- FSTR 3.34
- PRQR N/A
- Revenue
- FSTR $504,237,000.00
- PRQR $21,212,711.00
- Revenue This Year
- FSTR $3.80
- PRQR N/A
- Revenue Next Year
- FSTR $3.63
- PRQR N/A
- P/E Ratio
- FSTR $7.23
- PRQR N/A
- Revenue Growth
- FSTR N/A
- PRQR 85.91
- 52 Week Low
- FSTR $14.23
- PRQR $1.07
- 52 Week High
- FSTR $29.78
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- FSTR 74.10
- PRQR 68.07
- Support Level
- FSTR $23.41
- PRQR $2.10
- Resistance Level
- FSTR $24.61
- PRQR $2.18
- Average True Range (ATR)
- FSTR 0.68
- PRQR 0.13
- MACD
- FSTR 0.35
- PRQR 0.01
- Stochastic Oscillator
- FSTR 85.82
- PRQR 54.55
About FSTR L.B. Foster Company
L.B. Foster Co is a us-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.